Community-acquired Bacterial Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Bacterial Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Study of Fluid Collection of the Chest in Children With Pneumonia [Phase 3]
Phase 3 clinical trial investigating fluid collection of the chest in children with pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia [Phase 3]
Phase 3 trial comparing delafloxacin to moxifloxacin for adults with community-acquired bacterial pneumonia has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Phase II Study of Oral Nafithromycin in CABP [Phase 2]
Phase II study of oral nafithromycin in community-acquired bacterial pneumonia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia [Phase 2, Phase 3]
Phase 2/3 clinical trial of solithromycin in adolescents and children with community-acquired bacterial pneumonia has terminated; results po…
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13) [Phase 3]
Phase 3 trial comparing omadacycline to moxifloxacin for community-acquired bacterial pneumonia has completed with results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia [Phase 3]
A Phase 3 trial comparing oral solithromycin (CEM-101) to oral moxifloxacin for community-acquired bacterial pneumonia has completed, with e…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia [Phase 3]
Phase 3 efficacy and safety comparison of intravenous-to-oral solithromycin (CEM-101) versus moxifloxacin for community-acquired bacterial p…
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Clinical trial evaluating the safety and effectiveness of tigecycline in subjects with complicated skin and skin structure infections and co…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus [Phase 4]
Phase 4 clinical trial evaluating ceftaroline fosamil versus a comparator in adults with community-acquired bacterial pneumonia at risk for …
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia [Phase 3]
Phase 3 trial comparing intravenous ceftaroline with ceftriaxone in adults hospitalized with community-acquired bacterial pneumonia; complet…